Association of antipsychotic drugs on type 2 diabetes mellitus risk in patients with schizophrenia: a population-based cohort and in vitro glucose homeostasis-related gene expression study - Fang, Yi-Jen; Lee, Wan-Yi; Lin, Cheng-Li; Cheah, Yu-Cun; Hsieh, Hui-Hsia; Chen, Chi-Hua; Tsai, Fuu-Jen; Tien, Ni; Lim, Yun-Ping (BMC psychiatry, 2024)
Keywords: Adult; Antipsychotic Agents - adverse effects; Antipsychotic Agents - therapeutic use; Antipsychotic drugs; Antipsychotic medications; Antipsychotics; Cardiovascular disease; Cell lines; Chronic illnesses; Cohort study; Complications and side effects; Dextrose; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - epidemiology; Diabetes Mellitus, Type 2 - genetics; Diabetes therapy; Dopamine; Drug therapy; Drugs; Female; Gene expression; Gene Expression - drug effects; Gene Expression - genetics; Genes; Gluconeogenesis; Glucose; Glucose - metabolism; Glucose homeostasis; Health insurance; Hepatocytes; Homeostasis; Homeostasis - drug effects; Humans; Hyperglycemia; Hyperlipidemia; Hypertension; Incidence; Insulin resistance; Liver; Male; Medical research; Medicine, Experimental; Mental disorders; Middle Aged; Mortality; Patients; Population; Population studies; Psychotropic drugs; Retrospective Studies; Risk Factors; Schizophrenia; Schizophrenia - drug therapy; Schizophrenia - epidemiology; Schizophrenia - genetics; Taiwan - epidemiology; Type 2 diabetes; Type 2 diabetes mellitus; Taiwan; Antipsychotic medications; Schizophrenia; Type 2 diabetes mellitus; Glucose homeostasis; Cohort study